Ready, Set, Guidance: FDA Releases Final Details Ahead Of ASCA Pilot Launch
A trio of newly finalized guidance documents from the US agency dated 25 September explain how the Accreditation Scheme for Conformity Assessment pilot will work, and what biocompatibility and safety standards will apply.
You may also be interested in...
The US FDA detailed its proposed approach to the Accreditation Scheme for Conformity Assessment in a new draft guidance document. The ASCA will allow accredited labs to certify that manufacturers meet international conformance standards, which the agency hopes will help streamline the device approval process.
The US Department of Justice says the company provided advertising assistance and educational grants to health care providers that used its embolization devices.
The US FDA hopes to finalize or issue draft guidance documents on about 30 topics in fiscal year 2021.